Frequently Asked Questions MOUNJARO 7.5mg KwikPen is a multi-dose, single-patient pre-filled pen containing tirzepatide at an intermediate titration strength of 7.5mg per 0.6ml dose
4 Single-dose vials Discard unused portion Lilly PACKAGE LABEL - Zepbound Single-Dose Vial - 10 mg/0.5 mL Dose NDC 0002-1340-04 Zepbound (tirzepatide) injection 10 mg/0.5 mL Rx Only For Subcutaneous Use Needles and Syringes are not included Dispense enclosed Medication Guide to each patient
For researchers comparing these options against other medications, our tirzepatide vs semaglutide dosage comparison shows how the concentration and unit calculations differ between these two GLP-1 medications
Current research shows a possible association rather than confirmed causation, as patients taking semaglutide often have underlying risk factors including obesity and metabolic syndrome
Moreover, tirzepatide has depicted a dose-dependent correlation with weight loss, similar to other GLP-1 medications
How is the 2.5 mg starting dose drawn on a U-100 syringe